151 related articles for article (PubMed ID: 18283320)
1. Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation.
Baba Y; Iyama KI; Hirashima K; Nagai Y; Yoshida N; Hayashi N; Miyanari N; Baba H
Br J Cancer; 2008 Mar; 98(5):974-80. PubMed ID: 18283320
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
3. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Yamamoto H; Itoh F; Iku S; Hosokawa M; Imai K
Clin Cancer Res; 2001 Apr; 7(4):896-900. PubMed ID: 11309339
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
[TBL] [Abstract][Full Text] [Related]
5. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Shin WS; Hong Y; Lee HW; Lee ST
Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
[TBL] [Abstract][Full Text] [Related]
6. STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
Jiang W; Huang S; Song L; Wang Z
Oncol Rep; 2018 Feb; 39(2):834-842. PubMed ID: 29251330
[TBL] [Abstract][Full Text] [Related]
7. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
[TBL] [Abstract][Full Text] [Related]
8. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
[TBL] [Abstract][Full Text] [Related]
10. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
11. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
[TBL] [Abstract][Full Text] [Related]
14. Expression of laminin-5 and integrins in actinic cheilitis and superficially invasive squamous cell carcinomas of the lip.
Peixoto da-Silva J; Lourenço S; Nico M; Silva FH; Martins MT; Costa-Neves A
Pathol Res Pract; 2012 Oct; 208(10):598-603. PubMed ID: 22917688
[TBL] [Abstract][Full Text] [Related]
15. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
16. Biological and clinical significance of the YKL-40/osteopontin-integrin β4-p70S6K axis induced by macrophages in early oesophageal squamous cell carcinoma.
Urakami S; Koma YI; Tsukamoto S; Azumi Y; Miyako S; Kitamura Y; Kodama T; Nishio M; Shigeoka M; Abe H; Usami Y; Kodama Y; Yokozaki H
J Pathol; 2023 Sep; 261(1):55-70. PubMed ID: 37436683
[TBL] [Abstract][Full Text] [Related]
17. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.
Zhang J; Kong R; Sun L
Biomed Pharmacother; 2017 Jul; 91():402-407. PubMed ID: 28472755
[TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
19. Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.
Wong VC; Chan PL; Bernabeu C; Law S; Wang LD; Li JL; Tsao SW; Srivastava G; Lung ML
Int J Cancer; 2008 Dec; 123(12):2816-23. PubMed ID: 18798555
[TBL] [Abstract][Full Text] [Related]
20. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]